Stocks Health care ODTX
NASDAQ · Health careOdyssey Therapeutics, Inc. (ODTX)
At June 30, 2026 it held $82M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Odyssey Therapeutics, Inc. does
Odyssey Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker ODTX.
Latest SEC filings
What Odyssey Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 9, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- June 23, 2026
- June 17, 2026Quarterly report 10-Q · period to March 31, 2026
- June 17, 2026
- June 5, 2026Passive stake (5% or more) SCHEDULE 13G
- May 18, 2026Passive stake (5% or more) SCHEDULE 13G
- May 18, 2026Activist stake (5% or more) SCHEDULE 13D
- May 18, 2026Activist stake (5% or more) SCHEDULE 13D
Questions about ODTX
What does Odyssey Therapeutics, Inc. do?
Odyssey Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker ODTX.
When did Odyssey Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 9, 2026.
Similar companies
Follow ODTX
Get an email when Odyssey Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow ODTX: get an email when it filesWhere the numbers come from
Financial figures are the values Odyssey Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.